The Need for Ibogaine in Drug and Alcohol Addiction Treatment
Historical & modern Review moderate
⚠ Contains fatality data
AI-extracted · unverified · confirm at source
Legal commentary argues ibogaine should be rescheduled from Schedule I to II in the US, citing 83% withdrawal-free outcomes, societal costs of $181B/yr for drug abuse, and low abuse potential
Contraindications: Significantly impaired liver function, ECG abnormalities or previous heart problems, Severe mental health problems (schizophrenia, bipolar disorder), HIV positive or Hepatitis C symptomatic, Current antipsychotic medication use, Long-term medication with no prior data on ibogaine interactions, Narcotic analgesics, cocaine, amphetamines, or alcohol use within 12 hours prior to treatment